Form 4: AdaptHealth CFO Granted 126,899 Restricted Stock Units

AdaptHealth Corp.'s Chief Financial Officer, Jason A Clemens, was granted 126,899 restricted stock units, increasing his direct beneficial ownership.

Summary

• Jason A Clemens, Chief Financial Officer of AdaptHealth Corp. (AHCO), acquired 126,899 shares of common stock.
• These shares represent restricted stock units (RSUs) granted at a price of $0.
• The transaction occurred on January 30, 2026, and was made pursuant to a Rule 10b5-1(c) plan.
• Following this transaction, Mr. Clemens directly beneficially owns 673,481 shares of common stock.
• The RSUs will be settled in common stock upon vesting.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine, slightly positive event. While a Form 4 primarily reports a transaction, the grant of RSUs to a key executive like the CFO generally signals continued commitment and aligns management's interests with long-term shareholder value, which is a positive for corporate governance.

Positives

• The grant of 126,899 restricted stock units to the CFO aligns management's interests with long-term shareholder value.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-planned and transparent compensation arrangement.
• Increased beneficial ownership by a key executive can signal confidence in the company's future performance.

Future Outlook

The filing indicates that the restricted stock units will be settled in common stock upon vesting, implying a future conversion event tied to performance or time-based conditions, though specific vesting schedules are not detailed.

Management Comments

• These shares represent restricted stock units and will be settled in common stock upon vesting.

Industry Context

StockSavvy.ai notes that executive compensation, particularly through equity grants like RSUs, is a standard practice in the healthcare services industry, including home medical equipment and respiratory care providers like AdaptHealth. Such grants are designed to align executive incentives with long-term company performance and shareholder returns, a common strategy among peers to retain talent and drive strategic objectives.

Comparison to Industry Standards

• The grant of restricted stock units (RSUs) to a Chief Financial Officer is a common form of executive compensation across publicly traded companies, including those in the healthcare sector. For instance, similar equity-based incentives are routinely observed at companies like LHC Group (now part of UnitedHealth Group), Amedisys, Inc., and Encompass Health Corporation, where executive compensation packages often include a significant equity component to foster long-term alignment with shareholder interests. The specific number of units granted (126,899) would typically be benchmarked against the executive's role, company size, and performance metrics, though this filing does not provide the context for such a comparison.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of RSUs to the CFO aligns his financial interests with the company's long-term performance, potentially benefiting shareholders if the company's stock value increases.
• Employees: No direct impact on general employees is indicated by this executive compensation filing.
• Management: The CFO receives additional equity compensation, incentivizing continued performance and retention.

Next Steps

• The restricted stock units will vest according to a predetermined schedule, at which point they will be settled in common stock.

Key Dates

Recommendation

This Form 4 filing reports a routine executive compensation event (RSU grant) and does not contain information that would fundamentally alter the investment thesis for AdaptHealth Corp. While it indicates continued executive alignment, it's not a catalyst for a 'buy' or 'sell' recommendation. Investors should continue to 'hold' and monitor broader financial performance and strategic developments.

Keywords

AdaptHealth, AHCO, Form 4, Restricted Stock Units, RSU, CFO, Executive Compensation, Insider Ownership, Beneficial Ownership